businesswire.com

FDA Grants Orphan Drug Designation to Potential Pediatric Ulcerative Colitis Treatment

This morning, Seres Therapeutics announced that the FDA has granted Orphan Drug Designation to SER-287 for the treatment of Ulcerative Colitis in…
raredr.com